19/05/2025 - Research

According to a study by the Inflammatory Bowel Disease Research Group, severe obesity is a risk factor for developing Crohn’s disease and ulcerative colitis

This is the main conclusion of a study that analysed data over a fifteen-year period from one million individuals in Catalonia with obesity, severe obesity, or who had undergone bariatric surgery. Crohn's disease and ulcerative colitis are the main inflammatory bowel diseases, affecting around 100,000 people in Catalonia, which today marks World IBD Day.

08/05/2025 - Research

A new cell model to advance research into NF2-related schwannomatosis

A study led by the Clinical Genomics Unit (UGC) has established a new cell model to advance research into NF2-related schwannomatosis (SWN-NF2), a rare genetic disease. The work, published in the journal Genes & Disease, describes the generation and characterisation of cell spheroids derived from induced pluripotent stem cells (iPSC)-a type of stem cell capable of transforming into almost any cell type-that reproduce the alterations observed in tumours associated with the disease.

05/05/2025 - Research

HDAC11 deficiency improves muscle function and regeneration during ageing

Researchers from GRENBA-IGTP have identified the HDAC11 protein, an enzyme involved in cellular regulation, as a new therapeutic target to combat sarcopenia, the loss of muscle mass associated with ageing. The study shows that HDAC11 deficiency reduces muscle atrophy, preserves the muscle stem cell reservoir, promotes regeneration after injury and improves muscle function, opening the door to new strategies to support healthy ageing.

30/04/2025 - Campus Can Ruti, Research

A new mouse model allows for more accurate study of COVID-19 in humans

The study presents a new mouse model that more realistically mimics the disease caused by SARS-CoV-2 in humans, an essential tool for better understanding COVID.

24/04/2025 - Research

IGTP-led study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Researchers from the Endocrine Tumours group, in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns in metastatic differentiated thyroid cancer (DTC). Published in the journal Thyroid, the study identifies an epigenetic signature comprising 156 CpG sites in primary tumours that could help stratify patients according to their risk of developing distant metastases.

07/04/2025 - Projects, Research

A European study will analyse the impact of endocrine disruptors during pregnancy and the first 18 months of life

The research is part of the European project HYPIEND, coordinated by the Eurecat technology centre, and with the participation of IGTP-HUGTiP. 

21/03/2025 - Outreach, Research

The rise in Legionnaires’ disease cases challenges prevention efforts

To mark World Water Day, researcher Noemí Párraga focuses on Legionella. Despite advances in detection and prevention, case numbers continue to rise, highlighting the need to strengthen control measures in high-risk facilities.

18/03/2025 - Research

A study reveals sex differences in experimental liver cirrhosis

Researchers at IGTP have led a study that evaluates, for the first time, the difference between sexes in advanced liver disease in a rat model. The study has been published in the journal Laboratory Animals and has been conducted at the facilities of the CMCiB.

17/03/2025 - Projects, Research, Success Stories

The European project SMA-TB concludes with significant advances in tuberculosis treatment

The SMA-TB project, an initiative coordinated by the Experimental Tuberculosis Unit (UTE) at IGTP and funded by the European Commission's H2020 programme, has reached its conclusion after five years of research aimed at improving tuberculosis treatments.

14/03/2025 - Projects, Research

Symptoms of long-COVID can last up to two years after infection with COVID-19

According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID.